LINEAGE CELL THERAPEUTICS IN

Ticker: LCTX CUSIP: 53566P109 Class: COM

LAZARD ASSET MANAGEMENT LLC's Holding History (CIK: 0001207017)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 148 Value ($000) $0 Avg Close $0.73 Range $0.48 - $0.97
Q3 2024
Shares 148 Value ($000) $0 Avg Close $0.93 Range $0.77 - $1.15
Q2 2024
Shares 403 Value ($000) $0 Avg Close $1.10 Range $0.84 - $1.56
Q1 2024
Shares 6,059 Value ($000) $0 Avg Close $1.13 Range $0.84 - $1.61
Q4 2023
Shares 9,415 Value ($000) $0 Avg Close $1.10 Range $0.90 - $1.37
Q3 2023
Shares 8,837 Value ($000) $0 Avg Close $1.36 Range $1.15 - $1.54
Q2 2023
Shares 8,380 Value ($000) $0 Avg Close $1.38 Range $1.24 - $1.57
Q1 2023
Shares 8,066 Value ($000) $0 Avg Close $1.40 Range $1.16 - $1.58
Q4 2022
Shares 84,641 Value ($000) $0 Avg Close $1.26 Range $1.02 - $1.51
Q3 2022
Shares 77,974 Value ($000) $88 Avg Close $1.47 Range $1.11 - $1.79
Q4 2021
Shares 21,610 Value ($000) $52 Avg Close $2.34 Range $1.80 - $2.71